source
- Roivant reports Lisraya beats placebo in Phase 3 trials for non-infectious uveitisRoivant and its spinout Priovant announced that Lisraya, an immune-modifying oral drug, showed statistically significant benefit over placebo in two Phase 3 trials for non-infectious uveitis. The…
- Nigeria confirms travel-linked Ebola case tied to DRC outbreakNigeria's Ministry of Health announced a confirmed Ebola infection in a traveler, marking the country's first case linked to the ongoing outbreak in the Democratic Republic of the Congo. The patie…